Literature DB >> 15781133

Development of a cotton rat-human metapneumovirus (hMPV) model for identifying and evaluating potential hMPV antivirals and vaccines.

Philip R Wyde1, Srikrishna N Chetty, Alan M Jewell, Shauna L Schoonover, Pedro A Piedra.   

Abstract

Hispid cotton rats were inoculated with two different human metapneumovirus (hMPV) subtype A strains and one subtype B hMPV. Although no overt disease was seen in any virus-inoculated animal, following an eclipse phase, significant pulmonary virus titers were observed in every hMPV-inoculated animal through day 7 post virus inoculation (p.i.) and in most through day 10. Peak virus titers occurred four days p.i., while virus-induced histopathology was most evident in lung sections obtained from animals 7 to 10 days p.i. The latter consisted primarily of desquamating and hypertrophic columnar epithelial cells lining the bronchi and bronchioles and the presence of large numbers of leukocytes in and around the bronchi and bronchioles. In fluorescent antibody studies, virus antigen-specific fluorescence was most evident in the desquamating tall columnar epithelial cells lining bronchi and bronchioles, in pneumocytes lining alveoli and in single or small groups of free cells, most probably leukocytes, present in the lumen of alveoli, bronchi and bronchioles. Virus was generally not detected in inoculated animals >10 days p.i. Although the pattern of virus replication in cotton rats was similar for all the three virus stains, the B subtype consistently grew to lower levels than the two A strains. Regardless, these findings indicate that hMPV replicates in cotton rats and that these animals may be used as a small animal model of hMPV infection and to facilitate the identification and development of vaccines and antivirals for preventing and/or ameliorating infections caused by this virus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781133     DOI: 10.1016/j.antiviral.2004.12.009

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  22 in total

1.  Effect of ribavirin and glucocorticoid treatment in a mouse model of human metapneumovirus infection.

Authors:  Marie-Eve Hamelin; Gregory A Prince; Guy Boivin
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  A broadly neutralizing human monoclonal antibody exhibits in vivo efficacy against both human metapneumovirus and respiratory syncytial virus.

Authors:  Jennifer E Schuster; Reagan G Cox; Andrew K Hastings; Kelli L Boyd; Jay Wadia; Zhifeng Chen; Dennis R Burton; R Anthony Williamson; John V Williams
Journal:  J Infect Dis       Date:  2014-05-26       Impact factor: 5.226

3.  Programmed death-1 impairs secondary effector lung CD8⁺ T cells during respiratory virus reinfection.

Authors:  John J Erickson; Meredith C Rogers; Andrew K Hastings; Sharon J Tollefson; John V Williams
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

Review 4.  Human Metapneumovirus: lessons learned over the first decade.

Authors:  Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen
Journal:  Clin Microbiol Rev       Date:  2011-10       Impact factor: 26.132

5.  The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.

Authors:  John V Williams; Sharon J Tollefson; Joyce E Johnson; James E Crowe
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection.

Authors:  Deepthi Kolli; Efthalia L Bataki; Leanne Spetch; Antonieta Guerrero-Plata; Alan M Jewell; Pedro A Piedra; Gregg N Milligan; Roberto P Garofalo; Antonella Casola
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

7.  Identification of human metapneumovirus-induced gene networks in airway epithelial cells by microarray analysis.

Authors:  X Bao; M Sinha; T Liu; C Hong; B A Luxon; R P Garofalo; A Casola
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

8.  Burden of human metapneumovirus infection in young children.

Authors:  Kathryn M Edwards; Yuwei Zhu; Marie R Griffin; Geoffrey A Weinberg; Caroline B Hall; Peter G Szilagyi; Mary A Staat; Marika Iwane; Mila M Prill; John V Williams
Journal:  N Engl J Med       Date:  2013-02-14       Impact factor: 91.245

9.  DC-SIGN and L-SIGN Are Attachment Factors That Promote Infection of Target Cells by Human Metapneumovirus in the Presence or Absence of Cellular Glycosaminoglycans.

Authors:  Leah Gillespie; Kathleen Gerstenberg; Fernanda Ana-Sosa-Batiz; Matthew S Parsons; Rubaiyea Farrukee; Mark Krabbe; Kirsten Spann; Andrew G Brooks; Sarah L Londrigan; Patrick C Reading
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

10.  Airway epithelial cell response to human metapneumovirus infection.

Authors:  X Bao; T Liu; L Spetch; D Kolli; R P Garofalo; A Casola
Journal:  Virology       Date:  2007-07-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.